Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

Author： Moll E. Korevaar J.C. Bossuyt P.M.M. van der Veen F.

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.23, Iss.8, 2008-08, pp. : 1830-1834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Moll E. van Wely M. Lambalk C.B. Bossuyt P.M.M. van der Veen F.

Human Reproduction, Vol. 27, Iss. 11, 2012-11 ,pp. : 3273-3278

Oxford University Press

Access to resources Recommend Favorite

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

By Glueck Charles J. Wang Ping Goldenberg Naila Sieve-Smith Luann

Human Reproduction, Vol. 17, Iss. 11, 2002-11 ,pp. : 2858-2864

Oxford University Press

Access to resources Recommend Favorite

Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome

By Sönmez A.S.

Human Reproduction, Vol. 20, Iss. 1, 2005-01 ,pp. : 175-179

Oxford University Press

Access to resources Recommend Favorite

Sequential treatment of metformin and clomiphene citrate in clomiphene‐resistant women with polycystic ovary syndrome: a randomized, controlled trial

By George Susan Shanti

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 299-304

Oxford University Press

Access to resources Recommend Favorite

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

By Vanky E.

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1734-1740

Oxford University Press

Access to resources Recommend Favorite